| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.5 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |